São Caetano do Sul

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease2 trials
• Cervical cancer1 trial
• Endometrial cancer1 trial
• Familial hypercholesterolaemia1 trial
• Gastric and oesophageal cancer1 trial
• Head and neck cancer1 trial
• Heart failure1 trial
• High blood pressure1 trial
• Mesothelioma1 trial
• Ovarian cancer1 trial
• Prostate cancer1 trial
• Type 2 diabetes1 trial

Phase

• Phase 35 trials
• Phase 21 trial

Status

• Not yet recruiting3 trials
• Recruiting3 trials
• Active, not recruiting1 trial

Lead sponsor

• AstraZeneca7 trials

Running trials

• Recruiting

  Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer

  NCT07816666· Phase 3· AstraZeneca· Source

• Recruiting

  Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)

  NCT07711002· Phase 3· AstraZeneca· Source

• Recruiting

  A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

  NCT07624305· Phase 3· AstraZeneca· Source

  Contact: AstraZeneca Clinical AstraZeneca Clinical

• Recruiting

  Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  NCT07044336· Phase 3· AstraZeneca· Source

• Active, not recruiting

  A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH

  NCT07000136· Phase 3· AstraZeneca· Source

• Recruiting

  Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

  NCT06535607· Phase 2· AstraZeneca· Source

• Recruiting

  iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

  NCT03549754· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease2 recruiting
• Cervical cancer1 recruiting
• Endometrial cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Head and neck cancer1 recruiting
• Heart failure1 recruiting
• High blood pressure1 recruiting
• Mesothelioma1 recruiting
• Ovarian cancer1 recruiting
• Prostate cancer1 recruiting
• Type 2 diabetes1 recruiting